(2015) is the discovery and characterization paper for semaglutide, published in the Journal of Medicinal Chemistry
The top 3 rankings of semaglutide (71.5 points), dulaglutide (68.9 points), and liraglutide (68.7 points) were used as preferred drugs
A 2024 observational study by Wang and colleagues in Nature Communications used electronic health records from over 80,000 patients and found that patients with alcohol use disorder who were prescribed semaglutide had significantly lower rates of alcohol-related medical encounters compared to matched controls on other anti-diabetes medications
DOI: Published online: April 25, 2016 Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Rapid weight loss is one physical stressor that can cause this effect
As of mid-2025, retatrutide has not received marketing authorisation in the United Kingdom, the European Union, or the United States